Last edition
News about "Pharmaceutical Industry India"
Emcure Reports Robust Q1 FY27 Results, PAT Surges 36 Percent
Emcure Pharmaceuticals reported a strong Q1 FY27 with 22.8 percent revenue growth, 36.2 percent higher profit, improved margins, robust performance across key therapies, and over 15 product approvals in global markets.
Pharmaceutical Industry India | 07/08/2026 | By News Bureau | 132
India’s pharma and healthcare sector recorded 65 deals worth USD 13.9 billion in Q2 2026, with record M&A values driven by strategic acquisitions and continued investor focus on specialty pharma, AI-enabled healthcare and innovation-led businesses.
Pharmaceutical Industry India | 24/07/2026 | By News Bureau | 183
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy